OnKure Therapeutics, Inc. (OKUR)
3.10
-0.17
(-5.20%)
USD |
NASDAQ |
Sep 11, 16:00
3.08
-0.02
(-0.65%)
After-Hours: 20:00
OnKure Therapeutics Enterprise Value : -49.92M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | -49.92M |
| September 10, 2026 | -43.04M |
| September 09, 2026 | -38.58M |
| September 08, 2026 | -37.77M |
| September 04, 2026 | -30.48M |
| September 03, 2026 | -31.29M |
| September 02, 2026 | -32.10M |
| September 01, 2026 | -31.29M |
| August 31, 2026 | -28.46M |
| August 28, 2026 | -21.98M |
| August 27, 2026 | -20.36M |
| August 26, 2026 | -21.57M |
| August 25, 2026 | -19.55M |
| August 24, 2026 | -17.93M |
| August 21, 2026 | -15.90M |
| August 20, 2026 | -16.31M |
| August 19, 2026 | -10.24M |
| August 18, 2026 | -4.971M |
| August 17, 2026 | -9.020M |
| August 14, 2026 | -13.88M |
| August 13, 2026 | -17.52M |
| August 12, 2026 | -16.31M |
| August 11, 2026 | -9.830M |
| August 10, 2026 | -11.04M |
| August 07, 2026 | -7.805M |
| Date | Value |
|---|---|
| August 06, 2026 | -7.400M |
| August 05, 2026 | -6.995M |
| August 04, 2026 | -9.425M |
| August 03, 2026 | -12.66M |
| July 31, 2026 | -20.76M |
| July 30, 2026 | -13.47M |
| July 29, 2026 | -15.50M |
| July 28, 2026 | -15.50M |
| July 27, 2026 | -11.45M |
| July 24, 2026 | -8.615M |
| July 23, 2026 | -4.566M |
| July 22, 2026 | -0.516M |
| July 21, 2026 | -6.590M |
| July 20, 2026 | -8.615M |
| July 17, 2026 | -5.376M |
| July 16, 2026 | -9.425M |
| July 15, 2026 | -4.971M |
| July 14, 2026 | -4.566M |
| July 13, 2026 | -9.020M |
| July 10, 2026 | -2.136M |
| July 09, 2026 | 5.154M |
| July 08, 2026 | 5.963M |
| July 07, 2026 | 1.914M |
| July 06, 2026 | 10.82M |
| July 02, 2026 | 10.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | 991.92M |
| Theriva Biologics, Inc. | 3.579M |
| Yarrow Bioscience, Inc. | -4.874M |
| Nkarta, Inc. | 99.20M |
| Unicycive Therapeutics, Inc. | 86.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.35M |
| Total Expenses (Quarterly) | 15.35M |
| EPS Diluted (Quarterly) | -0.3077 |
| Earnings Yield | -112.8% |
| Normalized Earnings Yield | -112.76 |